Haemonetics Corporation  

(Public, NYSE:HAE)   Watch this stock  
Find more results for Black & White Corporations
33.54
-0.06 (-0.18%)
Apr 24 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 33.19 - 33.78
52 week 31.62 - 45.90
Open 33.71
Vol / Avg. 507,042.00/697,016.00
Mkt cap 1.74B
P/E 10.67
Div/yield     -
EPS 3.14
Shares 51.89M
Beta 0.59
Inst. own 108%
May 20, 2014
Haemonetics Investor Day - 10:00AM EDT - Add to calendar
Apr 28, 2014
Q4 2014 Haemonetics Corporation Earnings Release - 9:30AM EDT - Add to calendar
Apr 28, 2014
Q4 2014 Haemonetics Corporation Earnings Conference Call - 8:00AM EDT - Add to calendar
Mar 4, 2014
Haemonetics Corporation at Raymond James Financial Inc Institutional Investors Conference
Feb 24, 2014
Haemonetics Corporation at Citi Global Healthcare Conference
Feb 12, 2014
Haemonetics Corporation at Leerink Swann Global Healthcare Conference
Jan 27, 2014
Q3 2014 Haemonetics Corporation Earnings Release
Jan 27, 2014
Q3 2014 Haemonetics Corporation Earnings Conference Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin 6.73% 4.35%
Operating margin 7.38% 6.33%
EBITD margin - 14.15%
Return on average assets 4.40% 3.27%
Return on average equity 8.06% 5.17%
Employees 3,563 -
CDP Score - -

Address

400 WOOD RD
BRAINTREE, MA 02184
United States - Map
+1-781-8487100 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Haemonetics Corporation is a healthcare company engaged in providing blood management solutions to its customers. The Company�s portfolio of integrated devices, information management and consulting services offers blood management solutions for each facet of the blood supply chain, helping improve clinical outcomes and reduce costs for blood and plasma collectors, hospitals, and patients around the world.The Company serves three markets: manufacturers of plasma derived pharmaceuticals, blood collectors and hospitals. Plasma includes plasma collection devices and consumables. Blood Center includes blood collection and processing devices and consumables. Hospital includes surgical blood salvage and blood demand diagnostic devices and consumables. Software Solutions includes information technology platforms and consulting services provided to all three markets. On April 30, 2013, the Company acquired of certain assets of Hemerus LLC.

Officers and directors

Brian P. Concannon President, Chief Executive Officer, Director
Age: 55
Bio & Compensation  - Reuters
Christopher J. Lindop Chief Financial Officer, Executive Vice President - Business Development
Age: 55
Bio & Compensation  - Reuters
Peter M. Allen President - Global Plasma
Age: 54
Bio & Compensation  - Reuters
Kathleen Mcdaniel Executive Vice President - Global Human Resources
Age: 49
Bio & Compensation  - Reuters
David D. Helsel Executive Vice President - Global Manufacturing
Age: 49
Bio & Compensation  - Reuters
Warren Nighan Executive Vice President - Quality Assurance and Regulatory Assurance
Age: 44
Bio & Compensation  - Reuters
Jonathan White Chief Science and Technology Officer
Age: 53
Bio & Compensation  - Reuters
Susan Hanlon Chief Accounting Officer, Vice President - Finance
Age: 45
Bio & Compensation  - Reuters
Sandra Jesse Vice President, Chief Legal Officer
Age: 60
Bio & Compensation  - Reuters
Richard J. Meelia Non-Executive Independent Chairman of the Board
Age: 64
Bio & Compensation  - Reuters